查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513667

週边药物洗脱球囊的全球市场：产业分析、规模、占有率、成长、趋势与预测（2024-2033）

Peripheral Drug Eluting Balloon Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 273 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球週边药物洗脱球囊市场的综合研究报告。该报告全面评估了关键的市场动态，包括市场驱动因素、趋势、市场驱动因素、课题，并提供了有关市场结构的详细见解。

关键见解

  • 週边药物洗脱球囊市场规模（2024 年）：9.486 亿美元
  • 市场预测（2033 年）：19.505 亿美元
  • 全球市场成长率（2024-2033 年复合年增长率）：8.3%

週边药物洗脱球囊市场-调查范围

週边药物洗脱球囊透过将药物直接输送到动脉壁、抑制再狭窄和改善血流，在周边动脉疾病 (PAD) 的治疗中发挥重要作用。这些球囊用于各种医疗保健环境，包括医院、诊所和门诊中心，我们提供各种药物配方和球囊尺寸，以满足不同患者的需求。 PAD 盛行率的增加、球囊技术的进步以及对微创治疗的日益偏好正在推动市场成长。

市场驱动因素：

全球週边药物洗脱球囊市场受到几个关键因素的推动，其中包括影响全球数百万人的 PAD 盛行率上升。对提供持续药物输送和降低再狭窄率的有效治疗方案的需求正在推动药物洗脱球囊的采用。技术进步，例如开发具有改进的药物涂层和输送机制的下一代球囊，正在改善治疗效果和患者结果。此外，扩大采用微创手术和优惠的报销政策进一步促进了市场的成长。

市场限制因素：

儘管外围药物洗脱球囊市场有望实现成长，但仍面临新兴市场监管合规性、成本高和认知度低等课题。关于药物洗脱球囊的批准和使用的严格规定给製造商带来了巨大的合规负担。药物洗脱球囊和相关程序的高成本也对广泛使用构成了障碍，特别是在医疗保健预算有限的地区。此外，新兴国家对 PAD 和可用治疗方案的认识不足，阻碍了市场渗透。

市场机会

技术创新、人口趋势和医疗保健基础设施的扩张正在为週边药物洗脱球囊市场提供重大成长机会。将先进的药物配方和新的药物传输技术融入球囊装置中有望改善治疗效果并扩大应用范围。医疗保健基础设施投资不断增加，尤其是在新兴国家，预计将创造新的市场机会。策略联盟、研发投资以及实施具有成本效益的解决方案对于利用这些机会并保持市场领先地位至关重要。

本报告涵盖的主要问题

  • 推动週边药物洗脱球囊市场成长的关键因素是什么？
  • 哪些药物配方和应用正在推动外周药物洗脱球囊在各种医疗保健环境中的采用？
  • 技术进步如何改变週边药物洗脱球囊市场的竞争格局？
  • 谁是外围药物洗脱球囊市场的主要参与者？
  • 全球週边药物洗脱球囊市场的新趋势和未来前景如何？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含和排除

第三章主要市场趋势

  • 影响市场的主要趋势
  • 药物包衣创新/发展趋势

第 4 章增值见解

  • 依地区划分的产品采用/使用分析
  • 监管场景
  • 技术评估
  • 价值链分析
  • 最近的产品批准和发布
  • 波特的分析
  • 产品 USP 分析

第五章市场背景

  • 宏观经济因素
  • 预测因子 - 相关性和影响
  • 市场动态

第 6 章 COVID-19 危机分析

  • 新冠肺炎 (COVID-19) 与影响分析
    • 透过药物包衣
    • 依症状
    • 依动脉型
    • 依最终用户
    • 依地区
  • 2024 年市场情景

第七章全球市场需求量分析

  • 过去的市场量分析（2019-2023 年）
  • 目前与未来的市场量预测（2024-2033 年）
    • 年成长趋势分析

第 8 章世界市场 - 价格分析

  • 以药物包衣进行区域价格分析
  • 价格明细
    • 製造商等级定价
    • 经销商级定价
  • 世界平均价格分析基准
  • 定价假设

第九章全球市场需求（金额）分析

  • 过往市值分析（2019-2023 年）
  • 当前与未来市场价值的预测（2024-2033 年）
    • 年成长趋势分析
    • 绝对利润机会分析
  • 获利机会场景

第 10 章全球市场分析：依药物涂层分类

  • 简介/主要发现
  • 过去的市场规模与数量分析：依药物包衣分类（2019-2023）
  • 目前与未来的市场规模/数量分析/预测：依药物包衣划分（2024-2033 年）
    • 紫杉醇药物包衣
    • 西罗莫司药物包衣
    • 其他
  • 药物包衣的市场吸引力分析

第 11 章全球市场分析：依症状

  • 简介/主要发现
  • 过去的市场规模/数量分析：依症状分类（2019-2023 年）
  • 目前/未来的市场规模/数量分析/预测：依症状分类（2024-2033 年）
    • 週边动脉疾病
    • 週边动脉瘤
    • 支架内再狭窄
    • 其他
  • 症状市场吸引力分析

第 12 章全球市场分析：依动脉类型

  • 简介/主要发现
  • 过去的市场规模和交易量分析：依动脉类型划分（2019-2023 年）
  • 目前/未来市场规模/数量分析/预测：依动脉类型划分（2024-2033 年）
    • 颈动脉
    • 女性动脉
    • 髂动脉
    • 下动脉
  • 依动脉型进行市场吸引力分析

第 13 章全球市场分析：依最终使用者划分

  • 简介/主要发现
  • 过去的市场规模/数量分析：依最终用户划分（2019-2023 年）
  • 目前/未来的市场规模/数量分析/预测：依最终用户划分（2024-2033 年）
    • 医院
    • 日间手术中心/门诊
    • 心导管室
  • 最终用户的市场吸引力分析

第 14 章世界市场分析：依地区

  • 简介
  • 过去的市场规模/销售分析：依地区划分（2019-2023 年）
  • 当前与未来的市场价值/数量分析/预测：依地区划分（2024-2033 年）
    • 北美
    • 拉丁美洲
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东/非洲
  • 区域市场吸引力分析

第15章北美市场分析

第 16 章拉丁美洲市场分析

第 17 章欧洲市场分析

第18章东亚市场分析

第十九章南亚市场分析

第20章大洋洲市场

第21章中东/非洲市场分析

第22章市场结构分析

  • 依公司层级进行市场分析
  • 主要公司市占率分析
  • 市场现况分析

第23章竞争分析

  • 竞争对手仪表板
  • 製造商的品牌和促销策略
  • 主要发展分析
  • 衝突详情
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Cook Medical Inc.
    • MicroPort Scientific Corporation（Endovastec（TM））
    • Medtronic Plc.
    • Cardinal Health, Inc.
    • B. Braun Melsungen AG
    • BIOTRONIK SE &Co. KG
    • Becton, Dickinson and Company
    • WL Gore &Associates Inc.
    • Getinge AB
    • Terumo Corp
    • Kyoto Medical Planning Co Ltd
    • iVascular SLU
    • AMG International GmbH
    • ENDOCOR GmbH
    • Meril Life Sciences Pvt. Ltd.
    • Nano Therapeutics Pvt Ltd
    • Koninklijke Philips NV
    • REVA Medical

第 24 章先决条件与使用的缩写

第25章研究方法

简介目录
Product Code: PMRREP27211

Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral drug eluting balloons. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Peripheral Drug Eluting Balloons Market Size (2024E): USD 948.6Million
  • Projected Market Value (2033F): USD 1950.5 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 8.3%

Peripheral Drug Eluting Balloons Market - Report Scope:

Peripheral drug eluting balloons play a crucial role in the treatment of peripheral artery disease (PAD) by delivering medication directly to the arterial walls to inhibit restenosis and improve blood flow. These balloons are used in various healthcare settings, including hospitals, clinics, and outpatient centers, offering a range of drug formulations and balloon sizes to cater to different patient needs. Market growth is driven by the increasing prevalence of PAD, advancements in balloon technology, and a growing preference for minimally invasive procedures.

Market Growth Drivers:

The global peripheral drug eluting balloons market is propelled by several key factors, including the rising incidence of PAD, which affects millions of people worldwide. The demand for effective treatment options that offer sustained drug delivery and reduced restenosis rates is driving the adoption of drug eluting balloons. Technological advancements, such as the development of next-generation balloons with improved drug coatings and delivery mechanisms, enhance treatment efficacy and patient outcomes. Additionally, the increasing adoption of minimally invasive procedures and favorable reimbursement policies are further contributing to market growth.

Market Restraints:

Despite promising growth prospects, the peripheral drug eluting balloons market faces challenges related to regulatory compliance, high costs, and limited awareness in emerging markets. Stringent regulations governing the approval and use of drug eluting balloons impose significant compliance burdens on manufacturers. The high cost of these devices and associated procedures can also be a barrier to widespread adoption, particularly in regions with limited healthcare budgets. Furthermore, the lack of awareness about PAD and available treatment options in developing countries hinders market penetration.

Market Opportunities:

The peripheral drug eluting balloons market presents significant growth opportunities driven by technological innovations, demographic trends, and expanding healthcare infrastructure. The integration of advanced drug formulations and novel delivery technologies into balloon devices is expected to enhance therapeutic outcomes and broaden the application scope. Increasing investments in healthcare infrastructure, particularly in emerging economies, are anticipated to create new market opportunities. Strategic collaborations, investment in R&D, and the introduction of cost-effective solutions are essential to capitalize on these opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the peripheral drug eluting balloons market globally?
  • Which drug formulations and applications are driving the adoption of peripheral drug eluting balloons across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the peripheral drug eluting balloons market?
  • Who are the key players contributing to the peripheral drug eluting balloons market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global peripheral drug eluting balloons market?

Competitive Intelligence and Business Strategy:

Leading players in the global peripheral drug eluting balloons market, including Medtronic, B. Braun Melsungen AG, and Boston Scientific Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced drug eluting balloon solutions, including devices with enhanced drug coatings and delivery systems, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving peripheral drug eluting balloons landscape.

Key Companies Profiled:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec(TM))
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical

Key Segments of Peripheral Drug Eluting Balloons Industry Research

Drug Coating:

  • Paclitaxel Drug Coating
  • Sirolimus drug Coating

Indication:

  • Peripheral Arterial Disease
  • Peripheral Aneurysms
  • In-Stent Restenosis

Artery Type:

  • Carotid Arteries
  • Fem-Pop Arteries
  • Iliac Arteries
  • Infrapop Arteries

End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Drug Coating Innovation / Development Trends

4. Value Added Insights

  • 4.1. Product Adoption/ Usage Analysis, by region
  • 4.2. Regulatory Scenario
  • 4.3. Technology Assessment
  • 4.4. Value Chain Analysis
  • 4.5. Recent Product Approvals and Launches
  • 4.6. Porter's Analysis
  • 4.7. Product USP Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Peripheral Vascular Devices Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growth in Healthcare Spending
    • 5.2.2. Growth in Geriatric Population
    • 5.2.3. Rising Number of Peripheral Surgeries
    • 5.2.4. Technological Advancements
    • 5.2.5. Regulatory Landscape
    • 5.2.6. Cost of Procedures
    • 5.2.7. Product Adoption Rate and Demand
    • 5.2.8. Increase in Research and Development
    • 5.2.9. Pharmaceutical Industry Consolidation Activities
    • 5.2.10. Top Companies' Historical Growth
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Drug Coating
    • 6.1.2. By Indication
    • 6.1.3. By Artery Type
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand in Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Drug Coating
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis
  • 9.3. Revenue Opportunity Scenario

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Drug Coating

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Drug Coating, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, by Drug Coating, 2024-2033
    • 10.3.1. Paclitaxel Drug Coating
    • 10.3.2. Sirolimus drug Coating
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis, by Drug Coating

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Indication, 2024-2033
    • 11.3.1. Peripheral Arterial Disease
    • 11.3.2. Peripheral Aneurysms
    • 11.3.3. In-Stent Restenosis
    • 11.3.4. Others
  • 11.4. Market Attractiveness Analysis, by Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Artery Type

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Artery Type, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Artery Type, 2024-2033
    • 12.3.1. Carotid Artery
    • 12.3.2. Fem-Pop Artery
    • 12.3.3. Iliac Artery
    • 12.3.4. Infrapop Artery
  • 12.4. Market Attractiveness Analysis, by Artery Type

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2024-2033
    • 13.3.1. Hospitals
    • 13.3.2. Ambulatory Surgical Centers/Outpatients
    • 13.3.3. Cardiac Catheterization Labs
  • 13.4. Market Attractiveness Analysis, by End User

14. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Region, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, By Region, 2024-2033
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. South Asia
    • 14.3.5. East Asia
    • 14.3.6. Oceania
    • 14.3.7. Middle East and Africa (MEA)
  • 14.4. Market Attractiveness Analysis, by Region

15. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. U.S.
      • 15.3.1.2. Canada
    • 15.3.2. By Drug Coating
    • 15.3.3. By Indication
    • 15.3.4. By Artery Type
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Drug Coating
    • 15.4.3. By Indication
    • 15.4.4. By Artery Type
    • 15.4.5. By End User
  • 15.5. PESTLE Analysis
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis
  • 15.9. Country Level Analysis & Forecast
    • 15.9.1. U.S. Market Analysis
      • 15.9.1.1. Introduction
      • 15.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.9.1.2.1. By Drug Coating
        • 15.9.1.2.2. By Indication
        • 15.9.1.2.3. By Artery Type
        • 15.9.1.2.4. By End User
    • 15.9.2. Canada Market Analysis
      • 15.9.2.1. Introduction
      • 15.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.9.2.2.1. By Drug Coating
        • 15.9.2.2.2. By Indication
        • 15.9.2.2.3. By Artery Type
        • 15.9.2.2.4. By End User

16. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Mexico
      • 16.3.1.2. Brazil
      • 16.3.1.3. Argentina
      • 16.3.1.4. Rest of Latin America
    • 16.3.2. By Drug Coating
    • 16.3.3. By Indication
    • 16.3.4. By Artery Type
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Drug Coating
    • 16.4.3. By Indication
    • 16.4.4. By Artery Type
    • 16.4.5. By End User
  • 16.5. PESTLE Analysis
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis
  • 16.9. Country Level Analysis & Forecast
    • 16.9.1. Mexico Market Analysis
      • 16.9.1.1. Introduction
      • 16.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.9.1.2.1. By Drug Coating
        • 16.9.1.2.2. By Indication
        • 16.9.1.2.3. By Artery Type
        • 16.9.1.2.4. By End User
    • 16.9.2. Brazil Market Analysis
      • 16.9.2.1. Introduction
      • 16.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.9.2.2.1. By Drug Coating
        • 16.9.2.2.2. By Indication
        • 16.9.2.2.3. By Artery Type
        • 16.9.2.2.4. By End User
    • 16.9.3. Argentina Market Analysis
      • 16.9.3.1. Introduction
      • 16.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.9.3.2.1. By Drug Coating
        • 16.9.3.2.2. By Indication
        • 16.9.3.2.3. By Artery Type
        • 16.9.3.2.4. By End User

17. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Germany
      • 17.3.1.2. Italy
      • 17.3.1.3. France
      • 17.3.1.4. U.K.
      • 17.3.1.5. Spain
      • 17.3.1.6. BENELUX
      • 17.3.1.7. Russia
      • 17.3.1.8. Nordic Countries
      • 17.3.1.9. Rest of Europe
    • 17.3.2. By Drug Coating
    • 17.3.3. By Indication
    • 17.3.4. By Artery Type
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Drug Coating
    • 17.4.3. By Indication
    • 17.4.4. By Artery Type
    • 17.4.5. By End User
  • 17.5. PESTLE Analysis
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis
  • 17.9. Country Level Analysis & Forecast
    • 17.9.1. Germany Market Analysis
      • 17.9.1.1. Introduction
      • 17.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.1.2.1. By Drug Coating
        • 17.9.1.2.2. By Indication
        • 17.9.1.2.3. By Artery Type
        • 17.9.1.2.4. By End User
    • 17.9.2. Italy Market Analysis
      • 17.9.2.1. Introduction
      • 17.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.2.2.1. By Drug Coating
        • 17.9.2.2.2. By Indication
        • 17.9.2.2.3. By Artery Type
        • 17.9.2.2.4. By End User
    • 17.9.3. France Market Analysis
      • 17.9.3.1. Introduction
      • 17.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.3.2.1. By Drug Coating
        • 17.9.3.2.2. By Indication
        • 17.9.3.2.3. By Artery Type
        • 17.9.3.2.4. By End User
    • 17.9.4. U.K. Market Analysis
      • 17.9.4.1. Introduction
      • 17.9.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.4.2.1. By Drug Coating
        • 17.9.4.2.2. By Indication
        • 17.9.4.2.3. By Artery Type
        • 17.9.4.2.4. By End User
    • 17.9.5. Spain Market Analysis
      • 17.9.5.1. Introduction
      • 17.9.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.5.2.1. By Drug Coating
        • 17.9.5.2.2. By Indication
        • 17.9.5.2.3. By Artery Type
        • 17.9.5.2.4. By End User
    • 17.9.6. BENELUX Market Analysis
      • 17.9.6.1. Introduction
      • 17.9.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.6.2.1. By Drug Coating
        • 17.9.6.2.2. By Indication
        • 17.9.6.2.3. By Artery Type
        • 17.9.6.2.4. By End User
    • 17.9.7. Russia Market Analysis
      • 17.9.7.1. Introduction
      • 17.9.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.7.2.1. By Drug Coating
        • 17.9.7.2.2. By Indication
        • 17.9.7.2.3. By Artery Type
        • 17.9.7.2.4. By End User
    • 17.9.8. Nordic Countries Market Analysis
      • 17.9.8.1. Introduction
      • 17.9.8.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.9.8.2.1. By Drug Coating
        • 17.9.8.2.2. By Indication
        • 17.9.8.2.3. By Artery Type
        • 17.9.8.2.4. By End User

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market End User (US$ Mn) Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Drug Coating
    • 18.3.3. By Indication
    • 18.3.4. By Artery Type
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Drug Coating
    • 18.4.3. By Indication
    • 18.4.4. By Artery Type
    • 18.4.5. By End User
  • 18.5. PESTLE Analysis
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis
  • 18.9. Country Level Analysis & Forecast
    • 18.9.1. China Market Analysis
      • 18.9.1.1. Introduction
      • 18.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.9.1.2.1. By Drug Coating
        • 18.9.1.2.2. By Indication
        • 18.9.1.2.3. By Artery Type
        • 18.9.1.2.4. By End User
    • 18.9.2. Japan Market Analysis
      • 18.9.2.1. Introduction
      • 18.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.9.2.2.1. By Drug Coating
        • 18.9.2.2.2. By Indication
        • 18.9.2.2.3. By Artery Type
        • 18.9.2.2.4. By End User
    • 18.9.3. South Korea Market Analysis
      • 18.9.3.1. Introduction
      • 18.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.9.3.2.1. By Drug Coating
        • 18.9.3.2.2. By Indication
        • 18.9.3.2.3. By Artery Type
        • 18.9.3.2.4. By End User

19. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. India
      • 19.3.1.2. Indonesia
      • 19.3.1.3. Malaysia
      • 19.3.1.4. Thailand
      • 19.3.1.5. Rest of South Asia
    • 19.3.2. By Drug Coating
    • 19.3.3. By Indication
    • 19.3.4. By Artery Type
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Drug Coating
    • 19.4.3. By Indication
    • 19.4.4. By Artery Type
    • 19.4.5. By End User
  • 19.5. PESTLE Analysis
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis
  • 19.9. Country Level Analysis & Forecast
    • 19.9.1. India Market Analysis
      • 19.9.1.1. Introduction
      • 19.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.9.1.2.1. By Drug Coating
        • 19.9.1.2.2. By Indication
        • 19.9.1.2.3. By Artery Type
        • 19.9.1.2.4. By End User
    • 19.9.2. Indonesia Market Analysis
      • 19.9.2.1. Introduction
      • 19.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.9.2.2.1. By Drug Coating
        • 19.9.2.2.2. By Indication
        • 19.9.2.2.3. By Artery Type
        • 19.9.2.2.4. By End User
    • 19.9.3. Malaysia Market Analysis
      • 19.9.3.1. Introduction
      • 19.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.9.3.2.1. By Drug Coating
        • 19.9.3.2.2. By Indication
        • 19.9.3.2.3. By Artery Type
        • 19.9.3.2.4. By End User
    • 19.9.4. Thailand Market Analysis
      • 19.9.4.1. Introduction
      • 19.9.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.9.4.2.1. By Drug Coating
        • 19.9.4.2.2. By Indication
        • 19.9.4.2.3. By Artery Type
        • 19.9.4.2.4. By End User

20. Oceania Market 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. Australia
      • 20.3.1.2. New Zealand
    • 20.3.2. By Drug Coating
    • 20.3.3. By Indication
    • 20.3.4. By Artery Type
    • 20.3.5. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Drug Coating
    • 20.4.3. By Indication
    • 20.4.4. By Artery Type
    • 20.4.5. By End User
  • 20.5. PESTLE Analysis
  • 20.6. Market Trends
  • 20.7. Key Market Participants - Intensity Mapping
  • 20.8. Drivers and Restraints - Impact Analysis
  • 20.9. Country Level Analysis & Forecast
    • 20.9.1. Australia Market Analysis
      • 20.9.1.1. Introduction
      • 20.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.9.1.2.1. By Drug Coating
        • 20.9.1.2.2. By Indication
        • 20.9.1.2.3. By Artery Type
        • 20.9.1.2.4. By End User
    • 20.9.2. New Zealand Market Analysis
      • 20.9.2.1. Introduction
      • 20.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.9.2.2.1. By Drug Coating
        • 20.9.2.2.2. By Indication
        • 20.9.2.2.3. By Artery Type
        • 20.9.2.2.4. By End User

21. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 21.3. Current and Future Market Value (US$ Mn) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Turkey
      • 21.3.1.3. Israel
      • 21.3.1.4. South Africa
      • 21.3.1.5. North Africa
      • 21.3.1.6. Rest of Middle East and Africa
    • 21.3.2. By Drug Coating
    • 21.3.3. By Indication
    • 21.3.4. By Artery Type
    • 21.3.5. By End User
  • 21.4. Market Attractiveness Analysis
    • 21.4.1. By Country
    • 21.4.2. By Drug Coating
    • 21.4.3. By Indication
    • 21.4.4. By Artery Type
    • 21.4.5. By End User
  • 21.5. PESTLE Analysis
  • 21.6. Market Trends
  • 21.7. Key Market Participants - Intensity Mapping
  • 21.8. Drivers and Restraints - Impact Analysis
  • 21.9. Country Level Analysis & Forecast
    • 21.9.1. GCC Countries Market Analysis
      • 21.9.1.1. Introduction
      • 21.9.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.1.2.1. By Drug Coating
        • 21.9.1.2.2. By Indication
        • 21.9.1.2.3. By Artery Type
        • 21.9.1.2.4. By End User
    • 21.9.2. Turkey Market Analysis
      • 21.9.2.1. Introduction
      • 21.9.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.2.2.1. By Drug Coating
        • 21.9.2.2.2. By Indication
        • 21.9.2.2.3. By Artery Type
        • 21.9.2.2.4. By End User
    • 21.9.3. Israel Africa Market Analysis
      • 21.9.3.1. Introduction
      • 21.9.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.3.2.1. By Drug Coating
        • 21.9.3.2.2. By Indication
        • 21.9.3.2.3. By Artery Type
        • 21.9.3.2.4. By End User
    • 21.9.4. South Africa Market Analysis
      • 21.9.4.1. Introduction
      • 21.9.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.4.2.1. By Drug Coating
        • 21.9.4.2.2. By Indication
        • 21.9.4.2.3. By Artery Type
        • 21.9.4.2.4. By End User
    • 21.9.5. North Africa Market Analysis
      • 21.9.5.1. Introduction
      • 21.9.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 21.9.5.2.1. By Drug Coating
        • 21.9.5.2.2. By Indication
        • 21.9.5.2.3. By Artery Type
        • 21.9.5.2.4. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis, by Tier of Companies
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Branding and Promotional Strategies, By Manufacturers
  • 23.3. Key Development Analysis
  • 23.4. Competition Deep Dive
    • 23.4.1. Abbott Laboratories
      • 23.4.1.1. Overview
      • 23.4.1.2. Product Portfolio
      • 23.4.1.3. Sales Footprint
      • 23.4.1.4. Key Financials
      • 23.4.1.5. SWOT Analysis
      • 23.4.1.6. Key Developments
      • 23.4.1.7. Strategy Overview
        • 23.4.1.7.1. Marketing Strategy
        • 23.4.1.7.2. Product Strategy
        • 23.4.1.7.3. Channel Strategy
    • 23.4.2. Boston Scientific Corporation
      • 23.4.2.1. Overview
      • 23.4.2.2. Product Portfolio
      • 23.4.2.3. Sales Footprint
      • 23.4.2.4. Key Financials
      • 23.4.2.5. SWOT Analysis
      • 23.4.2.6. Key Developments
      • 23.4.2.7. Strategy Overview
        • 23.4.2.7.1. Marketing Strategy
        • 23.4.2.7.2. Product Strategy
        • 23.4.2.7.3. Channel Strategy
    • 23.4.3. Cook Medical Inc.
      • 23.4.3.1. Overview
      • 23.4.3.2. Product Portfolio
      • 23.4.3.3. Sales Footprint
      • 23.4.3.4. Key Financials
      • 23.4.3.5. SWOT Analysis
      • 23.4.3.6. Key Developments
      • 23.4.3.7. Strategy Overview
        • 23.4.3.7.1. Marketing Strategy
        • 23.4.3.7.2. Product Strategy
        • 23.4.3.7.3. Channel Strategy
    • 23.4.4. MicroPort Scientific Corporation (Endovastec(TM))
      • 23.4.4.1. Overview
      • 23.4.4.2. Product Portfolio
      • 23.4.4.3. Sales Footprint
      • 23.4.4.4. Key Financials
      • 23.4.4.5. SWOT Analysis
      • 23.4.4.6. Key Developments
      • 23.4.4.7. Strategy Overview
        • 23.4.4.7.1. Marketing Strategy
        • 23.4.4.7.2. Product Strategy
        • 23.4.4.7.3. Channel Strategy
    • 23.4.5. Medtronic Plc.
      • 23.4.5.1. Overview
      • 23.4.5.2. Product Portfolio
      • 23.4.5.3. Sales Footprint
      • 23.4.5.4. Key Financials
      • 23.4.5.5. SWOT Analysis
      • 23.4.5.6. Key Developments
      • 23.4.5.7. Strategy Overview
        • 23.4.5.7.1. Marketing Strategy
        • 23.4.5.7.2. Product Strategy
        • 23.4.5.7.3. Channel Strategy
    • 23.4.6. Cardinal Health, Inc.
      • 23.4.6.1. Overview
      • 23.4.6.2. Product Portfolio
      • 23.4.6.3. Sales Footprint
      • 23.4.6.4. Key Financials
      • 23.4.6.5. SWOT Analysis
      • 23.4.6.6. Key Developments
      • 23.4.6.7. Strategy Overview
        • 23.4.6.7.1. Marketing Strategy
        • 23.4.6.7.2. Product Strategy
        • 23.4.6.7.3. Channel Strategy
    • 23.4.7. B. Braun Melsungen AG
      • 23.4.7.1. Overview
      • 23.4.7.2. Product Portfolio
      • 23.4.7.3. Sales Footprint
      • 23.4.7.4. Key Financials
      • 23.4.7.5. SWOT Analysis
      • 23.4.7.6. Key Developments
      • 23.4.7.7. Strategy Overview
        • 23.4.7.7.1. Marketing Strategy
        • 23.4.7.7.2. Product Strategy
        • 23.4.7.7.3. Channel Strategy
    • 23.4.8. BIOTRONIK SE & Co. KG
      • 23.4.8.1. Overview
      • 23.4.8.2. Product Portfolio
      • 23.4.8.3. Sales Footprint
      • 23.4.8.4. Key Financials
      • 23.4.8.5. SWOT Analysis
      • 23.4.8.6. Key Developments
      • 23.4.8.7. Strategy Overview
        • 23.4.8.7.1. Marketing Strategy
        • 23.4.8.7.2. Product Strategy
        • 23.4.8.7.3. Channel Strategy
    • 23.4.9. Becton, Dickinson and Company
      • 23.4.9.1. Overview
      • 23.4.9.2. Product Portfolio
      • 23.4.9.3. Sales Footprint
      • 23.4.9.4. Key Financials
      • 23.4.9.5. SWOT Analysis
      • 23.4.9.6. Key Developments
      • 23.4.9.7. Strategy Overview
        • 23.4.9.7.1. Marketing Strategy
        • 23.4.9.7.2. Product Strategy
        • 23.4.9.7.3. Channel Strategy
    • 23.4.10. W. L. Gore & Associates Inc.
      • 23.4.10.1. Overview
      • 23.4.10.2. Product Portfolio
      • 23.4.10.3. Sales Footprint
      • 23.4.10.4. Key Financials
      • 23.4.10.5. SWOT Analysis
      • 23.4.10.6. Key Developments
      • 23.4.10.7. Strategy Overview
        • 23.4.10.7.1. Marketing Strategy
        • 23.4.10.7.2. Product Strategy
        • 23.4.10.7.3. Channel Strategy
    • 23.4.11. Getinge AB
      • 23.4.11.1. Overview
      • 23.4.11.2. Product Portfolio
      • 23.4.11.3. Sales Footprint
      • 23.4.11.4. Key Financials
      • 23.4.11.5. SWOT Analysis
      • 23.4.11.6. Key Developments
      • 23.4.11.7. Strategy Overview
        • 23.4.11.7.1. Marketing Strategy
        • 23.4.11.7.2. Product Strategy
        • 23.4.11.7.3. Channel Strategy
    • 23.4.12. Terumo Corp
      • 23.4.12.1. Overview
      • 23.4.12.2. Product Portfolio
      • 23.4.12.3. Sales Footprint
      • 23.4.12.4. Key Financials
      • 23.4.12.5. SWOT Analysis
      • 23.4.12.6. Key Developments
      • 23.4.12.7. Strategy Overview
        • 23.4.12.7.1. Marketing Strategy
        • 23.4.12.7.2. Product Strategy
        • 23.4.12.7.3. Channel Strategy
    • 23.4.13. Kyoto Medical Planning Co Ltd
      • 23.4.13.1. Overview
      • 23.4.13.2. Product Portfolio
      • 23.4.13.3. Sales Footprint
      • 23.4.13.4. Key Financials
      • 23.4.13.5. SWOT Analysis
      • 23.4.13.6. Key Developments
      • 23.4.13.7. Strategy Overview
        • 23.4.13.7.1. Marketing Strategy
        • 23.4.13.7.2. Product Strategy
        • 23.4.13.7.3. Channel Strategy
    • 23.4.14. iVascular S.L.U
      • 23.4.14.1. Overview
      • 23.4.14.2. Product Portfolio
      • 23.4.14.3. Sales Footprint
      • 23.4.14.4. Key Financials
      • 23.4.14.5. SWOT Analysis
      • 23.4.14.6. Key Developments
      • 23.4.14.7. Strategy Overview
        • 23.4.14.7.1. Marketing Strategy
        • 23.4.14.7.2. Product Strategy
        • 23.4.14.7.3. Channel Strategy
    • 23.4.15. AMG International GmbH
      • 23.4.15.1. Overview
      • 23.4.15.2. Product Portfolio
      • 23.4.15.3. Sales Footprint
      • 23.4.15.4. Key Financials
      • 23.4.15.5. SWOT Analysis
      • 23.4.15.6. Key Developments
      • 23.4.15.7. Strategy Overview
        • 23.4.15.7.1. Marketing Strategy
        • 23.4.15.7.2. Product Strategy
        • 23.4.15.7.3. Channel Strategy
    • 23.4.16. ENDOCOR GmbH
      • 23.4.16.1. Overview
      • 23.4.16.2. Product Portfolio
      • 23.4.16.3. Sales Footprint
      • 23.4.16.4. Key Financials
      • 23.4.16.5. SWOT Analysis
      • 23.4.16.6. Key Developments
      • 23.4.16.7. Strategy Overview
        • 23.4.16.7.1. Marketing Strategy
        • 23.4.16.7.2. Product Strategy
        • 23.4.16.7.3. Channel Strategy
    • 23.4.17. Meril Life Sciences Pvt. Ltd.
      • 23.4.17.1. Overview
      • 23.4.17.2. Product Portfolio
      • 23.4.17.3. Sales Footprint
      • 23.4.17.4. Key Financials
      • 23.4.17.5. SWOT Analysis
      • 23.4.17.6. Key Developments
      • 23.4.17.7. Strategy Overview
        • 23.4.17.7.1. Marketing Strategy
        • 23.4.17.7.2. Product Strategy
        • 23.4.17.7.3. Channel Strategy
    • 23.4.18. Nano Therapeutics Pvt Ltd
      • 23.4.18.1. Overview
      • 23.4.18.2. Product Portfolio
      • 23.4.18.3. Sales Footprint
      • 23.4.18.4. Key Financials
      • 23.4.18.5. SWOT Analysis
      • 23.4.18.6. Key Developments
      • 23.4.18.7. Strategy Overview
        • 23.4.18.7.1. Marketing Strategy
        • 23.4.18.7.2. Product Strategy
        • 23.4.18.7.3. Channel Strategy
    • 23.4.19. Koninklijke Philips N.V.
      • 23.4.19.1. Overview
      • 23.4.19.2. Product Portfolio
      • 23.4.19.3. Sales Footprint
      • 23.4.19.4. Key Financials
      • 23.4.19.5. SWOT Analysis
      • 23.4.19.6. Key Developments
      • 23.4.19.7. Strategy Overview
        • 23.4.19.7.1. Marketing Strategy
        • 23.4.19.7.2. Product Strategy
        • 23.4.19.7.3. Channel Strategy
    • 23.4.20. REVA Medical
      • 23.4.20.1. Overview
      • 23.4.20.2. Product Portfolio
      • 23.4.20.3. Sales Footprint
      • 23.4.20.4. Key Financials
      • 23.4.20.5. SWOT Analysis
      • 23.4.20.6. Key Developments
      • 23.4.20.7. Strategy Overview
        • 23.4.20.7.1. Marketing Strategy
        • 23.4.20.7.2. Product Strategy
        • 23.4.20.7.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology